Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrazione
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Azenta, Inc.
  6. Notizie
  7. Altre lingue
    AZTA   US1143401024

AZENTA, INC.

(AZTA)
  Rapporto
Tempo differito Nasdaq  -  22:00 30/09/2022
42.86 USD   -2.50%
16/08Azenta, Inc.: B. Riley rimane Buy
MM
10/08Azenta, Inc.: Needham & Co. conferma il rating Buy
MM
09/08Azenta riporta un utile rettificato più elevato nel terzo trimestre fiscale e fissa le prospettive per il quarto trimestre.
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivatiFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su AZENTA, INC.
14/09Transcript : Azenta, Inc. Presents at Baird 2022 Global Healthcare Conference..
13/09Transcript : Azenta, Inc. Presents at Morgan Stanley 20th Annual Global Healt..
06/09Azenta to Participate in the Baird 2022 Global Healthcare Conference
30/08Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
12/08Transcript : Azenta, Inc. Presents at UBS Genomics 2.0 and Medtech Innovation..
11/08Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conf..
11/08Good news keeps on coming
11/08Analyst recommendations: Micron Technology, Public Storage, Pion..
10/08Azenta: Announces Agreement to Acquire B Medical Systems - Form 8-K
10/08Azenta, Inc.: Entry into a Material Definitive Agreement, Other Events, Financial Stateme..
10/08Azenta: Q3 2022 Azenta Inc. Earnings Conference Call
10/08Azenta: Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
09/08Azenta Reports Higher Fiscal Q3 Adjusted Profit, Sets Q4 Outlook
09/08Azenta: Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 202..
09/08Azenta: Q3 2022 Earnings Call Presentation
09/08AZENTA, INC. Management's Discussion and Analysis of Financial Condition and Results o..
09/08Tranche Update on Azenta, Inc.'s Equity Buyback Plan announced on September 30, 2015.
09/08Brooks: Fiscal Q3 Earnings Snapshot
09/08Azenta Seeks M&A
09/08Transcript : Azenta, Inc., Q3 2022 Earnings Call, Aug 09, 2022
09/08Earnings Flash (AZTA) AZENTA Reports Q3 EPS $0.12
09/08Earnings Flash (AZTA) AZENTA Reports Q3 Revenue $132.7M
09/08Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 20..
09/08Azenta, Inc. Provides Earnings Guidance for the Fourth Quarter Fiscal 2022
09/08Azenta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June ..
08/08Azenta Announces Agreement to Acquire B Medical Systems
08/08Azenta, Inc. entered into an agreement to acquire B Medical Systems S.à R.L. for approx..
05/08Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
27/07Azenta Celebrates Opening of New China Headquarters
27/07Azenta, Inc. Announces Opening of its New China Headquarters in Suzhou
14/07MÄRKTE USA/Börse erholt von Tagestief - Zinsängste lassen nach
14/07Sector Update: Health Care Stocks Unable to Climb Back to Positive Ground
14/07Azenta Cuts Q3 Guidance; Shares Sink Thursday
14/07Sector Update: Health Care Stocks Declining Thursday with Broader Markets
14/07Sector Update: Health Care
14/07MÄRKTE USA/Wall Street erholt von Tagestief
14/07MÄRKTE USA/Wall Street weiter auf Talfahrt
14/07MÄRKTE USA/An Wall Street dürfte es weiter abwärts gehen
13/07Azenta: Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 2022..
13/07Azenta Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 202..
13/07Azenta, Inc. Provides Earnings Guidance for the Third Fiscal Quarter Ended June 30, 202..
01/07Azenta Completes Acquisition of Barkey
01/07Azenta Announces Completion of Barkey Holding GmbH Acquisition
24/06Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell 2500 Growth Index
24/06Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell Small Cap Comp Gr..
24/06Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell Midcap Growth Ind..
24/06Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell 1000 Growth Index
24/06Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell 3000 Growth Index
24/06Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell 3000E Growth Inde..
15/06Azenta: Announces Agreement to Acquire Barkey Holding GmbH - Form 8-K
15/06Azenta, Inc.: Entry into a Material Definitive Agreement, Other Events, Financial Stateme..
09/06Transcript : Azenta, Inc. Presents at 2022 Jefferies Global Healthcare Confer..
08/06Azenta: Announces Agreement to Acquire Barkey Holding GmbH - Form 8-K
08/06Azenta, Inc.: Entry into a Material Definitive Agreement, Other Events, Financial Stateme..
08/06Azenta Agrees to Acquire Barkey Holding for $86 Million
08/06Azenta Announces Agreement to Acquire Barkey Holding GmbH
02/06Azenta to Participate in the Jefferies Healthcare Conference
24/05Transcript : Azenta, Inc. Presents at UBS Global Healthcare Conference, May-2..
19/05Azenta to Participate in the UBS Global Healthcare Conference
16/05AZENTA, INC. Management's Discussion and Analysis of Financial Condition and Results o..
16/05Tranche Update on Azenta, Inc.'s Equity Buyback Plan announced on September 30, 2015.
09/05Brooks: Fiscal Q2 Earnings Snapshot
09/05Transcript : Azenta, Inc., Q2 2022 Earnings Call, May 09, 2022
09/05Azenta, Inc. Provides Revenue Guidance for the Third Quarter of 2022
09/05Azenta, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March..
09/05Earnings Flash (AZTA) AZENTA Posts Q2 EPS $0.12, vs. Street Est of $0.11
09/05Earnings Flash (AZTA) AZENTA Posts Q2 Revenue $145.5M, vs. Street Est of $142.1M
09/05Azenta Life Sciences Reports Preliminary Results of Second Quarter of Fiscal 2022, Ende..
28/04Azenta Reschedules Fiscal 2022 Second Quarter Earnings Conference Call and Webcast
28/04Azenta, Inc. Re-Affirms Revenue Guidance for the Second Fiscal Quarter of 2022 Which En..
28/04Azenta, Inc. Reschedules the Release of its Earnings for the Second Fiscal Quarter of 2..
14/04Azenta Life Sciences Announces Fiscal 2022 Second Quarter Earnings Conference Call and ..
12/04Azenta, Inc to Seek M&A
12/04Transcript : Azenta, Inc. Presents at Needham 21st Annual Healthcare Conferen..
07/04Azenta: Investor Overview April 2022
30/03Azenta to Participate in the 21st Annual Needham Virtual Healthcare Conference
22/03Transcript : Azenta, Inc. Presents at 2022 KeyBanc Capital Markets Life Scien..
15/03Transcript : Azenta, Inc. Presents at Barclays Global Healthcare Conference 2..
11/03Azenta to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor F..
08/03Azenta: Investor Overview March 2022
08/03Transcript : Azenta, Inc. Presents at 42nd Annual Cowen Health Care Conferenc..
01/03Azenta to Participate in the Barclays Global Healthcare Conference
25/02Azenta to Participate in the Cowen 42nd Annual Health Care Conference
15/02Azenta: Investor Overview February 2022
09/02AZENTA, INC. Management's Discussion and Analysis of Financial Condition and Results o..
09/02Tranche Update on Azenta, Inc.'s Equity Buyback Plan announced on September 30, 2015.
08/02Azenta Fiscal Q1 Non-GAAP Adjusted Net Income Slips as Revenue Rises; Fiscal Q2 Guidanc..
08/02Brooks: Fiscal Q1 Earnings Snapshot
08/02Transcript : Azenta, Inc., Q1 2022 Earnings Call, Feb 08, 2022
08/02Azenta: Q1 2022 Earnings Call Presentation
08/02Azenta: Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31,..
08/02Earnings Flash (AZTA) AZENTA Posts Q1 EPS $0.12, vs. Street Est of $0.08
08/02Earnings Flash (AZTA) AZENTA Posts Q1 Revenue $139.7M, vs. Street Est of $135.4M
08/02Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31..
08/02Azenta, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021
08/02Azenta, Inc. Provides Earnings Guidance for the Second Quarter Fiscal Year 2022
04/02Azenta Life Sciences to Participate in the BTIG MedTech, Digital Health, Life Science &..
01/02Azenta Closes $3 Billion Sale of Semiconductor Automation Business -- Shares Slump in L..
01/02Azenta: Life Sciences Completes Sale of Semiconductor Solutions Group Business to Thomas ..
01/02Azenta, Inc.: Entry into a Material Definitive Agreement, Termination of a Material Defin..